These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30183361)

  • 21. Performance validity testing in children and adolescents: A descriptive study comparing direct and embedded measures.
    Weiss SJ; Blackwell MC; Griffith KM; Jordan LS; Culotta VP
    Appl Neuropsychol Child; 2019; 8(2):158-162. PubMed ID: 29286844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rates of False-Positive Classification Resulting From the Analysis of Additional Embedded Performance Validity Measures.
    Silk-Eglit GM; Stenclik JH; Miele AS; Lynch JK; McCaffrey RJ
    Appl Neuropsychol Adult; 2015; 22(5):335-47. PubMed ID: 25584812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimizing false positive error with multiple performance validity tests: response to Bilder, Sugar, and Hellemann (2014 this issue).
    Larrabee GJ
    Clin Neuropsychol; 2014; 28(8):1230-42. PubMed ID: 25491180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-validation of three Advanced Clinical Solutions performance validity tests: Examining combinations of measures to maximize classification of invalid performance.
    Bain KM; Soble JR; Webber TA; Messerly JM; Bailey KC; Kirton JW; McCoy KJM
    Appl Neuropsychol Adult; 2021; 28(1):24-34. PubMed ID: 30987451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examination of the Modified Somatic Perception Questionnaire (MSPQ) in a large sample of credible and noncredible patients referred for neuropsychological testing.
    Balasanyan M; Boone KB; Ermshar A; Miora D; Cottingham M; Victor TL; Ziegler E; Zeller MA; Wright M
    Clin Neuropsychol; 2018 Jan; 32(1):165-182. PubMed ID: 28585455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance validity in undergraduate research participants: a comparison of failure rates across tests and cutoffs.
    An KY; Kaploun K; Erdodi LA; Abeare CA
    Clin Neuropsychol; 2017 Jan; 31(1):193-206. PubMed ID: 27687709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptom and performance validity in samples of adults at clinical evaluation of ADHD: a replication study using machine learning algorithms.
    Hirsch O; Fuermaier ABM; Tucha O; Albrecht B; Chavanon ML; Christiansen H
    J Clin Exp Neuropsychol; 2022 Apr; 44(3):171-184. PubMed ID: 35906728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting noncredible performance with the neuropsychological assessment battery, screening module: A simulation study.
    Lace JW; Grant AF; Ruppert P; Kaufman DAS; Teague CL; Lowell K; Gfeller JD
    Clin Neuropsychol; 2021 Apr; 35(3):572-596. PubMed ID: 31790343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of embedded performance validity tests on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) following mild traumatic brain injury.
    Lippa SM; Lange RT; Bhagwat A; French LM
    Appl Neuropsychol Adult; 2017; 24(1):73-80. PubMed ID: 27077512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TOMM Trial 1 as a performance validity indicator in a criminal forensic sample.
    Fazio RL; Denning JH; Denney RL
    Clin Neuropsychol; 2017 Jan; 31(1):251-267. PubMed ID: 27456971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The MMPI-2/MMPI-2-RF Symptom Validity Scale (FBS/FBS-r) is not a measure of 'litigation response syndrome': commentary on Nichols and Gass (2015).
    Larrabee GJ; Bianchini KJ; Boone KB; Rohling ML
    Clin Neuropsychol; 2017 Nov; 31(8):1387-1395. PubMed ID: 28829224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Embedded performance validity testing in neuropsychological assessment: Potential clinical tools.
    Rickards TA; Cranston CC; Touradji P; Bechtold KT
    Appl Neuropsychol Adult; 2018; 25(3):219-230. PubMed ID: 28139144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Red flags in the clinical interview may forecast invalid neuropsychological testing.
    Keesler ME; McClung K; Meredith-Duliba T; Williams K; Swirsky-Sacchetti T
    Clin Neuropsychol; 2017 Apr; 31(3):619-631. PubMed ID: 27846775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Betting on DBS: Effects of subthalamic nucleus deep brain stimulation on risk taking and decision making in patients with Parkinson's disease.
    Brandt J; Rogerson M; Al-Joudi H; Reckess G; Shpritz B; Umeh CC; Aljehani N; Mills K; Mari Z
    Neuropsychology; 2015 Jul; 29(4):622-631. PubMed ID: 25486385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lowered cutoffs to reduce false positives on the Word Memory Test.
    Rohling ML; Demakis GJ; Langhinrichsen-Rohling J
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):67-79. PubMed ID: 38362939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreasing battery life in subthalamic deep brain stimulation for Parkinson's disease with repeated replacements: Just a matter of energy delivered?
    Israeli-Korn SD; Fay-Karmon T; Tessler S; Yahalom G; Benizri S; Strauss H; Zibly Z; Spiegelmann R; Hassin-Baer S
    Brain Stimul; 2019; 12(4):845-850. PubMed ID: 30876884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease.
    Qureshi AA; Cheng JJ; Sunshine AN; Wu A; Pontone GM; Cascella N; Lenz FA; Grill SE; Anderson WS
    Neurosurg Focus; 2015 Jun; 38(6):E5. PubMed ID: 26030705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevations on select Conners' CPT-II scales indicate noncredible responding in adults with traumatic brain injury.
    Erdodi LA; Pelletier CL; Roth RM
    Appl Neuropsychol Adult; 2018; 25(1):19-28. PubMed ID: 27662418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.